What Role for Adefovir?
Low-dose adefovir is a promising agent for patients with 3TC-resistant hepatitis B virus infection. Higher doses, however, were not associated with virologic or immunologic benefits in a large study of patients with HIV infection and were associated with considerable nephrotoxicity.
Welcome to Journal Watch. The content you requested requires sign in with a username and password.
Sign In
Sign Up
Print subscribers
Activate your free online account for full access to all site content and features.
Other visitors
Subscribe for full access to all site content and features. ($99/year)
Purchase a site pass for full access to all articles. ($19/7 days)
Or, simply register for free access to email alerts, site features, and article archives. (FREE)